Gilead Sciences, Inc. (GILD)
146.76
+0.64
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
146.50
-0.26
(-0.18%)
After-Hours: 20:00
Gilead Sciences Price : 146.76 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 144.52 | 147.90 | 143.50 | 146.12 | 5.385M |
| Aug 20, 2026 | 146.69 | 146.82 | 143.19 | 143.44 | 7.168M |
| Aug 19, 2026 | 145.10 | 148.97 | 144.30 | 147.60 | 6.739M |
| Aug 18, 2026 | 140.00 | 143.89 | 139.54 | 143.44 | 5.759M |
| Aug 17, 2026 | 138.36 | 139.49 | 136.63 | 138.92 | 3.940M |
| Aug 14, 2026 | 136.81 | 138.43 | 135.91 | 138.36 | 3.408M |
| Aug 13, 2026 | 136.94 | 138.30 | 136.03 | 138.14 | 4.897M |
| Aug 12, 2026 | 133.99 | 137.12 | 133.30 | 135.87 | 5.684M |
| Aug 11, 2026 | 132.68 | 136.85 | 132.01 | 135.77 | 5.494M |
| Aug 10, 2026 | 131.61 | 134.32 | 131.61 | 133.06 | 6.834M |
| Aug 07, 2026 | 132.10 | 134.09 | 130.59 | 133.21 | 8.202M |
| Aug 06, 2026 | 133.99 | 134.48 | 129.02 | 130.86 | 9.235M |
| Aug 05, 2026 | 136.00 | 137.80 | 129.60 | 131.76 | 11.38M |
| Aug 04, 2026 | 131.15 | 135.57 | 129.54 | 135.25 | 10.09M |
| Aug 03, 2026 | 131.10 | 131.50 | 129.04 | 131.15 | 7.524M |
| Jul 31, 2026 | 130.23 | 130.88 | 128.76 | 130.21 | 6.532M |
| Jul 30, 2026 | 130.02 | 131.39 | 128.28 | 131.28 | 6.726M |
| Jul 29, 2026 | 134.41 | 134.64 | 132.56 | 132.73 | 7.766M |
| Jul 28, 2026 | 133.11 | 136.26 | 132.63 | 134.32 | 6.947M |
| Jul 27, 2026 | 131.00 | 133.06 | 129.43 | 130.52 | 4.954M |
| Jul 24, 2026 | 130.93 | 131.65 | 129.04 | 129.31 | 5.530M |
| Jul 23, 2026 | 129.22 | 131.07 | 127.61 | 130.86 | 6.299M |
| Jul 22, 2026 | 131.83 | 132.86 | 130.23 | 130.34 | 4.758M |
| Jul 21, 2026 | 130.51 | 132.86 | 129.13 | 130.28 | 8.371M |
| Jul 20, 2026 | 134.28 | 135.50 | 132.91 | 133.21 | 4.104M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 547.74 |
| AbbVie, Inc. | 264.49 |
| Regeneron Pharmaceuticals, Inc. | 828.72 |
| Amgen, Inc. | 443.84 |
| Biogen, Inc. | 218.11 |
Price Related Metrics
| PS Ratio | 6.011 |
| Price to Book Value | 15.40 |
| Price to Free Cash Flow | 14.19 |
| Earnings Yield | -1.81% |
| Market Cap | 182.13B |
| Operating PE Ratio | 15.39 |
| Normalized PE Ratio | 30.89 |